Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hypertension

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 63 articles:
HTML format



Single Articles


    October 2021
  1. MIHAILIDOU AS, Gulati M
    Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION.
    Eur Heart J. 2021 Oct 18. pii: 6399973. doi: 10.1093.
    PubMed    


  2. BOUCHERON P, Lailler G, Moutengou E, Regnault N, et al
    Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION study.
    Eur Heart J. 2021 Oct 13. pii: 6395270. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  3. RUILOPE LM, Valenzuela PL, Lucia A
    Digital therapeutics and lifestyle: the start of a new era in the management of arterial hypertension?
    Eur Heart J. 2021 Sep 27. pii: 6377082. doi: 10.1093.
    PubMed    


  4. CREA F
    The ESC Guidelines on heart failure, sacubitril-valsartan in resistant hypertension, and new therapeutic targets in myocardial hypertrophy.
    Eur Heart J. 2021;42:3581-3585.
    PubMed    


  5. FUKUMOTO Y
    Takayasu arteritis-associated pulmonary hypertension.
    Eur Heart J. 2021 Sep 20. pii: 6372800. doi: 10.1093.
    PubMed    


  6. LINZ D, Gawalko M, Sanders P, Penders J, et al
    Does gut microbiota affect atrial rhythm? Causalities and speculations.
    Eur Heart J. 2021;42:3521-3525.
    PubMed     Abstract available


  7. BAYES-GENIS A, Diez J
    Transition to heart failure in hypertension: going to the heart of the matter.
    Eur Heart J. 2021 Sep 13. pii: 6369562. doi: 10.1093.
    PubMed    


  8. JIANG X, Zhu YJ, Zhou YP, Peng FH, et al
    Clinical features and survival in Takayasu's arteritis-associated pulmonary hypertension: a nationwide study.
    Eur Heart J. 2021 Sep 10. pii: 6368314. doi: 10.1093.
    PubMed     Abstract available


  9. BROWN JM, Zhou W, Weber B, Divakaran S, et al
    Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease.
    Eur Heart J. 2021 Sep 7. pii: 6365821. doi: 10.1093.
    PubMed     Abstract available


  10. MESSERLI FH, Bavishi C, Messerli AW, Siontis GCM, et al
    Cerebrotoxicity of antihypertensive therapy in the UK Biobank Cohort Study.
    Eur Heart J. 2021 Sep 4. pii: 6364086. doi: 10.1093.
    PubMed    


    August 2021
  11. KARIO K, Nomura A, Harada N, Okura A, et al
    Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial.
    Eur Heart J. 2021 Aug 29. pii: 6358480. doi: 10.1093.
    PubMed     Abstract available


  12. VOLPE M, Gallo G
    Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension: one shot for a double strike?
    Eur Heart J. 2021 Aug 15. pii: 6352588. doi: 10.1093.
    PubMed    


  13. JACKSON AM, Jhund PS, Anand IS, Dungen HD, et al
    Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.
    Eur Heart J. 2021 Aug 15. pii: 6352587. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  14. VOLPE M, Patrono C
    The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profile.
    Eur Heart J. 2021;42:2814-2815.
    PubMed    


    June 2021
  15. VOLPE M, Patrono C
    A SPRINT towards tighter control of blood pressure in hypertension.
    Eur Heart J. 2021 Jun 25. pii: 6309731. doi: 10.1093.
    PubMed    


  16. HE FJ, Campbell NRC, Woodward M, MacGregor GA, et al
    Salt reduction to prevent hypertension: the reasons of the controversy.
    Eur Heart J. 2021 Jun 12. pii: 6297147. doi: 10.1093.
    PubMed     Abstract available


  17. MESSERLI FH, Brguljan J, Rexhaj E, Sever P, et al
    Lowering systolic blood pressure to 120 mmHg or The Lancet's true grit.
    Eur Heart J. 2021;42:2052-2059.
    PubMed    


  18. YAN Y, Mu J
    Salt intake paradox: the estimation method matters.
    Eur Heart J. 2021;42:2133.
    PubMed    


    May 2021
  19. LANDMESSER U, Lehmann I, Eils R
    Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19.
    Eur Heart J. 2021;42:1720-1721.
    PubMed    


    April 2021

  20. Erratum to: A cohort study and meta-analysis of isolated diastolic hypertension: searching for a threshold to guide treatment.
    Eur Heart J. 2021 Apr 13. pii: 6224359. doi: 10.1093.
    PubMed    


    March 2021
  21. MANNUCCI PM, Ancona C
    Noise and air pollution as triggers of hypertension.
    Eur Heart J. 2021 Mar 22. pii: 6179518. doi: 10.1093.
    PubMed    


  22. VAN DIEPEN S, Armstrong PW
    Learning whether to subtract beta-blockers: it's about time.
    Eur Heart J. 2021;42:915-918.
    PubMed     Abstract available


    February 2021
  23. ESTRUCH R, Ruilope LM, Cosentino F
    The year in cardiovascular medicine 2020: epidemiology and prevention.
    Eur Heart J. 2021;42:813-821.
    PubMed    


  24. WARTOLOWSKA KA, Webb AJS
    Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study.
    Eur Heart J. 2021;42:750-757.
    PubMed     Abstract available


    January 2021
  25. PEREZ DE ISLA L, Watts GF, Alonso R, Diaz-Diaz JL, et al
    Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
    Eur Heart J. 2021 Jan 12. pii: 6091158. doi: 10.1093/eurheartj/ehaa1066.
    PubMed     Abstract available


    December 2020
  26. MESSERLI FH, Bavishi C, Messerli AW, Siontis GCM, et al
    On cerebrotoxicity of antihypertensive therapy and risk factor cosmetics.
    Eur Heart J. 2020 Dec 28. pii: 6054230. doi: 10.1093.
    PubMed    


  27. SALAH HM, Arthur JM, Mehta JL
    Implications of renal ACE2 expression in the age of COVID-19.
    Eur Heart J. 2020;41:4589-4591.
    PubMed    


  28. CREA F
    Focus on hypertension but also on the 'the digital twin' and on kidney function and disease.
    Eur Heart J. 2020;41:4531-4534.
    PubMed    


  29. LA GERCHE A
    Proof that exercise works, now it's time for optimizing delivery to our patients with pulmonary hypertension.
    Eur Heart J. 2020 Dec 12. pii: 6031923. doi: 10.1093.
    PubMed    


    November 2020
  30. GRUNIG E, MacKenzie A, Peacock AJ, Eichstaedt CA, et al
    Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial.
    Eur Heart J. 2020 Nov 24. pii: 6000268. doi: 10.1093.
    PubMed     Abstract available



  31. Relates to: 'Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction: Hygia Chronotherapy Trial' by Ramon C. Hermida et al. Eur Heart J 2020; https://doi.org/10.1093/eurheartj/ehz754.
    Eur Heart J. 2020 Nov 22. pii: 5998316. doi: 10.1093.
    PubMed    


  32. LIEW CH, McEvoy JW
    The diastolic blood pressure J-curve remains an observational research phenomenon that has not yet been proven as causal and should not be used to make invasive treatment decisions.
    Eur Heart J. 2020;41:4284-4285.
    PubMed    


  33. GUO TT, Tan JS, Wu Y, Gao X, et al
    Balloon pulmonary angioplasty with distal embolic protection device for chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2020 Nov 12. pii: 5979515. doi: 10.1093.
    PubMed    


  34. VOLPE M, Patrono C
    Decline in blood pressure control trends in the US: a real step back: Comment on National Health and Nutrition Examination Survey (NHANES) data.
    Eur Heart J. 2020;41:3986-3987.
    PubMed    


    October 2020
  35. JIANG X, Eales JM, Scannali D, Nazgiewicz A, et al
    Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney.
    Eur Heart J. 2020 Oct 27. pii: 5940440. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  36. VENKATA C, Ram S
    Dr Norman M. Kaplan (1931-2020): a giant in the field of hypertension has departed.
    Eur Heart J. 2020 Sep 25. pii: 5911422. doi: 10.1093.
    PubMed    


    July 2020
  37. VOLPE M, Battistoni A
    Genes and hypertension: stepping into the secret through the arterial wall.
    Eur Heart J. 2020 Jul 29. pii: 5877875. doi: 10.1093.
    PubMed    


  38. ESCANED J, Lerman LO
    Coronary microcirculation and hypertensive heart failure.
    Eur Heart J. 2020;41:2376-2378.
    PubMed    


    June 2020
  39. ROMMEL KP, Lurz P
    Transcatheter tricuspid valve repair and pulmonary hypertension: navigating through troubled waters.
    Eur Heart J. 2020 Jun 30. pii: 5865477. doi: 10.1093.
    PubMed    


  40. D'ALTO M, Naeije R
    Transcatheter tricuspid valve repair in patients with pulmonary hypertension.
    Eur Heart J. 2020 Jun 30. pii: 5865473. doi: 10.1093.
    PubMed    


  41. RUILOPE LM, Tamargo J, Ruiz-Hurtado G
    Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs.
    Eur Heart J. 2020 Jun 4. pii: 5851433. doi: 10.1093.
    PubMed    


  42. GAO C, Cai Y, Zhang K, Zhou L, et al
    Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.
    Eur Heart J. 2020 Jun 4. pii: 5851436. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  43. ZHU WW, Lv XZ, Li WH
    Hereditary haemorrhagic telangiectasia with heritable pulmonary arterial hypertension.
    Eur Heart J. 2020 May 26. pii: 5846239. doi: 10.1093.
    PubMed    


    April 2020
  44. KUSTER GM, Osswald S
    Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence.
    Eur Heart J. 2020 Apr 23. pii: 5824224. doi: 10.1093.
    PubMed    


  45. CIULLA MM
    Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19.
    Eur Heart J. 2020 Apr 23. pii: 5824223. doi: 10.1093.
    PubMed    



  46. Relates to: 'Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction: Hygia Chronotherapy Trial'.
    Eur Heart J. 2020;41:1600.
    PubMed    


  47. LUSCHER TF
    Unanswered questions in hypertension: prematurity and long-term trajectories, masked and white coat hypertension.
    Eur Heart J. 2020;41:1527-1530.
    PubMed    


  48. HERMIDA RC, Mojon A, Fernandez JR
    Comparing the design of the primary-care based Hygia Chronotherapy Trial and the Internet-Based TIME Study.
    Eur Heart J. 2020;41:1608.
    PubMed    


  49. HERMIDA RC, Crespo JJ, Dominguez-Sardina M
    Improved reduction of cardiovascular risk by bedtime ingestion of ARB and ACEI medication class therapies.
    Eur Heart J. 2020;41:1602-1603.
    PubMed    


  50. KELM M
    Early birth affects vascular function.
    Eur Heart J. 2020;41:1551-1553.
    PubMed    


  51. GUTHRIE G, Poulter N, Macdonald T, Ford I, et al
    Chronotherapy in hypertension: the devil is in the details.
    Eur Heart J. 2020 Apr 19. pii: 5822566. doi: 10.1093.
    PubMed    


  52. SANCHEZ-SANCHEZ C, Lopez-Caballero C, Contreras I, Puerto B, et al
    Is bedtime treatment appropriate for all hypertensive patients?
    Eur Heart J. 2020 Apr 18. pii: 5822039. doi: 10.1093.
    PubMed    


  53. HERMIDA RC, Fernandez JR, Mojon A
    Chronotherapy of hypertension, asleep ambulatory blood pressure, and glaucoma.
    Eur Heart J. 2020 Apr 18. pii: 5822040. doi: 10.1093.
    PubMed    


  54. SEN S, Kaskal M, Uresin Y
    Chrono-pharmacological effects of antihypertensive drugs.
    Eur Heart J. 2020 Apr 16. pii: 5820905. doi: 10.1093.
    PubMed    


  55. LARSON S, Cho MC, Tsioufis K, Yang E, et al
    2018 Korean Society of Hypertension Guidelinefor the Management of Hypertension: A Comparison of American, European, and Korean Blood Pressure Guidelines.
    Eur Heart J. 2020;41:1384-1386.
    PubMed    


    March 2020
  56. ZHOU W, Brown JM, Bajaj NS, Chandra A, et al
    Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure.
    Eur Heart J. 2020 Mar 28. pii: 5813079. doi: 10.1093.
    PubMed     Abstract available


  57. JACOBSEN AP, Al Rifai M, Arps K, Whelton SP, et al
    A cohort study and meta-analysis of isolated diastolic hypertension: searching for a threshold to guide treatment.
    Eur Heart J. 2020 Mar 2. pii: 6157020. doi: 10.1093.
    PubMed     Abstract available


  58. COCA A
    Blood pressure and cardiovascular disease: are diastolic values 80-89 mmHg enough to define hypertension?
    Eur Heart J. 2020 Mar 2. pii: 6157019. doi: 10.1093.
    PubMed    


  59. BOHM M, Ferreira JP, Mahfoud F, Duarte K, et al
    Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial.
    Eur Heart J. 2020 Mar 2. pii: 5771273. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  60. ZHOU Y, Wen J, Nie J
    How much can acute heart failure patients with low basic blood pressure (systolic blood pressure 90-100 mmHg) benefit from the use of vasodilators?
    Eur Heart J. 2020 Jan 10. pii: 5700445. doi: 10.1093.
    PubMed    


    November 2019
  61. LUSCHER TF
    Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes.
    Eur Heart J. 2019;40:3579-3582.
    PubMed    


    May 2019
  62. SHARASHOVA E, Wilsgaard T, Ball J, Morseth B, et al
    Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromso Study.
    Eur Heart J. 2019 May 3. pii: 5485289. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  63. CHAO TF, Lip GYH, Lin YJ, Chang SL, et al
    Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.
    Eur Heart J. 2019 Jan 2. pii: 5272355. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: